Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Inactivated SARS-CoV-2 vaccine in primary Sjögren's syndrome: humoral response, safety, and effects on disease activity.
Pasoto SG, Halpern ASR, Guedes LKN, Ribeiro ACM, Yuki ENF, Saad CGS, da Silva CAA, de Vinci Kanda Kupa L, Villamarín LEB, de Oliveira Martins VA, Martins CCMF, Deveza GBH, Leon EP, Bueno C, Pedrosa TN, Santos REB, Soares R, Aikawa NE, Bonfa E. Pasoto SG, et al. Among authors: pedrosa tn. Clin Rheumatol. 2022 Jul;41(7):2079-2089. doi: 10.1007/s10067-022-06134-x. Epub 2022 Mar 19. Clin Rheumatol. 2022. PMID: 35306594 Free PMC article. Clinical Trial.
Understanding the dynamics of hydroxychloroquine blood levels in lupus nephritis.
Pedrosa TN, Pasoto SG, Aikawa NE, Yuki EF, Borba EF, Filho JCF, Carricondo PC, Zanetti CB, Conde PG, Duarte NJ, Fontoura N, Romano P, Carvalho VM, Silva CA, Bonfa E. Pedrosa TN, et al. Lupus. 2020 May;29(6):560-568. doi: 10.1177/0961203320912832. Epub 2020 Mar 19. Lupus. 2020. PMID: 32192398 No abstract available.
Systemic autoimmune myopathies: a prospective phase 4 controlled trial of an inactivated virus vaccine against SARS-CoV-2.
Shinjo SK, de Souza FHC, Borges IBP, Dos Santos AM, Miossi R, Misse RG, Medeiros-Ribeiro AC, Saad CGS, Yuki EFN, Pasoto SG, Kupa LVK, Ceneviva C, Seraphim JC, Pedrosa TN, Vendramini MBG, Silva CA, Aikawa NE, Bonfá E. Shinjo SK, et al. Among authors: pedrosa tn. Rheumatology (Oxford). 2022 Aug 3;61(8):3351-3361. doi: 10.1093/rheumatology/keab773. Rheumatology (Oxford). 2022. PMID: 34664616 Free PMC article. Clinical Trial.
SARS-CoV-2 vaccine in patients with systemic sclerosis: impact of disease subtype and therapy.
Sampaio-Barros PD, Medeiros-Ribeiro AC, Luppino-Assad AP, Miossi R, da Silva HC, Yuki EFVN, Pasoto SG, Saad CGS, Silva CA, Kupa LVK, Deveza GBH, Pedrosa TN, Aikawa NE, Bonfá E. Sampaio-Barros PD, et al. Among authors: pedrosa tn. Rheumatology (Oxford). 2022 Jun 28;61(SI2):SI169-SI174. doi: 10.1093/rheumatology/keab886. Rheumatology (Oxford). 2022. PMID: 34894235 Free PMC article. Clinical Trial.
Short-term Accrual 2019 European League Against Rheumatism/American College of Rheumatology Domains and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage in Lupus Patients With and Without Nephritis at Disease Onset.
Munhoz GA, Aikawa NE, Silva CA, Pasoto SG, Pedrosa TN, Seguro LPC, Bonfa E, Borba EF. Munhoz GA, et al. Among authors: pedrosa tn. J Clin Rheumatol. 2023 Jun 1;29(4):190-195. doi: 10.1097/RHU.0000000000001939. Epub 2023 Jan 21. J Clin Rheumatol. 2023. PMID: 36683233
In vitro safety and efficacy evaluations of a complex botanical mixture of Eugenia dysenterica DC. (Myrtaceae): Prospects for developing a new dermocosmetic product.
Moreira LC, de Ávila RI, Veloso DFMC, Pedrosa TN, Lima ES, do Couto RO, Lima EM, Batista AC, de Paula JR, Valadares MC. Moreira LC, et al. Among authors: pedrosa tn. Toxicol In Vitro. 2017 Dec;45(Pt 3):397-408. doi: 10.1016/j.tiv.2017.04.002. Epub 2017 Apr 4. Toxicol In Vitro. 2017. PMID: 28389280 Free article.